Literature DB >> 12552553

Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: initial clinical experience.

Jozef Masura1, Pavol Gavora, Tomaz Podnar.   

Abstract

In the present study, we report the initial clinical experience with the new angled Amplatzer duct occluder (ADO) for the percutaneous closure of patent ductus arteriosus (PDA). Percutaneous closure of PDA using standard ADO in infants and in patients with small PDA ampulla is difficult, or even impossible, due to protrusion of the aortic disk into the descending thoracic aorta. The aortic disk of an angled ADO is angled at 32 degrees to the body of the device and concave toward the aorta to prevent protrusion of the disk into the aorta. Percutaneous closure of PDA was attempted in nine patients with a median age of 5.2 years (range, 0.5-12.7) and median weight of 20 kg (range, 4.9-55). Selection of the occluder and the implantation technique were similar to the standard ADO. The minimal PDA diameter ranged from 2.1 to 3.7 mm (median, 2.5 mm). Occluders were successfully implanted in all patients. Immediate complete PDA closure was achieved in all patients. There were no complications. The new angled ADO is a safe and effective device for PDA closure, particularly suitable for infants and patients with small PDA ampulla. Further studies and long-term follow-up are necessary to confirm our initial experience. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12552553     DOI: 10.1002/ccd.10413

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

1.  Amplatzer angled duct occluder for closure of patent ductus arteriosus larger than the aorta in an infant.

Authors:  I B Vijayalakshmi; N Chitra; R Rajasri; A N Prabhudeva
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Challenges encountered during closure of patent ductus arteriosus.

Authors:  P Ewert
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Transesophageal echocardiography guided patent ductus arteriosus occlusion in adults with severe pulmonary hypertension through a parasternal approach.

Authors:  Xiao-Fu Dai; Liang-Wan Chen; Dong-Zhong Chen; Qiang Chen; Guo-Zhong Zhen; Gui-Can Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?

Authors:  Saktheeswaran Mahesh Kumar; Venkateshwaran Subramanian; Sasidharan Bijulal; Kavassery Mahadevan Krishnamoorthy; Sivasubramonian Sivasankaran; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

5.  Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children.

Authors:  G Butera; G De Rosa; M Chessa; L Piazza; A Delogu; A Frigiola; M Carminati
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

6.  Ductal closure in infants under 6 kg including premature infants using AmplatzerTM duct occluder type two additional sizes: a single-centre experience in South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Makrexeni; Samkelo Jiyana
Journal:  Cardiovasc J Afr       Date:  2019-08-30       Impact factor: 1.167

7.  The Amplatzer duct occluder for PDA closure: indications, technique of implantation and clinical outcome.

Authors:  W Boehm; M Emmel; N Sreeram
Journal:  Images Paediatr Cardiol       Date:  2007-04

Review 8.  Therapeutic Utilities of Pediatric Cardiac Catheterization.

Authors:  Giannis A Moustafa; Argyrios Kolokythas; Konstantinos Charitakis; Dimitrios V Avgerinos
Journal:  Curr Cardiol Rev       Date:  2016

9.  Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic.

Authors:  Lungile Pepeta; Adele Dippenaar
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

10.  Patent ductus arteriosus closure using Occlutech® Duct Occluder, experience in Port Elizabeth, South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Masonwabe Makrexeni
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.